REPH Recro Pharma Inc.

7.64
+0.07  (+1%)
Previous Close 7.57
Open 7.55
Price To Book 12.13
Market Cap 164088085
Shares 21,477,498
Volume 92,530
Short Ratio
Av. Daily Volume 154,546

SEC filingsSee all SEC filings

  1. 8-K - Current report 181225796
  2. 8-K - Current report 181164678
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 181164660
  4. 8-K - Current report 181111989
  5. 8-K - Current report 181095865

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL announced May 24, 2018. New PDUFA date March 24, 2019.
Intravenous (IV) meloxicam
Acute pain following bunionectomy surgery

SEC Filings

  1. 8-K - Current report 181225796
  2. 8-K - Current report 181164678
  3. 10-Q - Quarterly report [Sections 13 or 15(d)] 181164660
  4. 8-K - Current report 181111989
  5. 8-K - Current report 181095865
  6. 8-K - Current report 181072381
  7. 8-K - Current report 181053891
  8. 8-K - Current report 181051240
  9. 8-K - Current report 18996254
  10. 10-Q - Quarterly report [Sections 13 or 15(d)] 18996248